foundation medicine genomic testing laboratory
Foundation Medicine Campus

Foundation Medicine Inc.

Our work offers more than information; it can inspire hope in patients, families, friends, physicians, and caregivers.

Through constant innovation, we can make breakthroughs to help achieve improved outcomes for more individuals living with cancer. That’s why we foster a collaborative culture that motivates us to do our best work and be a partner in every patient's journey.

Our approach combines genomic profile products and data services to generate insights that may help doctors match patients to more treatment options and help accelerate the development of new therapies.

FOUNDATION FACTS

Foundation Medicine Support of the Clinical and Research Community

  • >150k1-3

    Patients Profiled

  • >30

    Biopharma Partners

  • >2504

    Published Manuscripts

FoundationOne® and FoundationOne® Heme are next-generation sequencing services performed by Foundation Medicine, Inc. at laboratories located in Cambridge, Massachusetts, USA. Hoffmann-La Roche Limited markets these services in Canada under an exclusive license from Foundation Medicine, Inc. The FoundationOne® and FoundationOne® Heme reports are prepared exclusively by Foundation Medicine, Inc., without Hoffmann-La Roche Limited’s involvement. The reports may include scientific information about experimental medicinal product(s) or uses that are not approved and/ or available in Canada. Hoffmann-La Roche Limited does not endorse or recommend the unapproved use of any medicinal product. FoundationOne® and FoundationOne® Heme are registered trade-marks of Foundation Medicine, Inc., used under license.